Arcturus Therapeutics
ARCT
#8492
Rank
โ‚น18.19 B
Marketcap
โ‚น640.53
Share price
4.39%
Change (1 day)
-60.37%
Change (1 year)

Revenue for Arcturus Therapeutics (ARCT)

Revenue in 2025 (TTM): โ‚น7.33 Billion

According to Arcturus Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น7.64 Billion. In 2024 the company made a revenue of โ‚น11.87 Billion a decrease over the revenue in the year 2023 that were of โ‚น13.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arcturus Therapeutics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น7.33 B-38.2%
2024 โ‚น11.87 B-9.6%
2023 โ‚น13.13 B-22.87%
2022 โ‚น17.02 B1750.89%
2021 โ‚น0.91 B31.86%
2020 โ‚น0.69 B-52.94%
2019 โ‚น1.48 B34.59%
2018 โ‚น1.10 B-13.98%
2017 โ‚น1.28 B
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚น12.49 B 63.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas